Eva-Maria W. D.
- Country
- Germany
- Department
- III. Med. Klinik u. Poliklinik Hämatologie u. Med. Onkologie
Research Overview
- Safety and Preliminary Efficacy of CTX112 in Adults with Relapsed or Refractory Hematologic Autoimmune Disease
- AZD0120 Versus Standard Regimens in Relapsed or Refractory Multiple Myeloma: A Phase III Randomised Study
- Evaluation of Apraglutide Efficacy and Safety in Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: A Randomized, Single-Blind Trial
Data & Insights
Has run more than one trial at 62 of 135 partner sites.
Specializations
Hematologic Disorders
This investigator specializes in treating multiple myeloma and evaluating novel therapeutic approaches, including comparing allogeneic stem cell transplantation with conventional therapies. Their work extends to studying combination treatments involving bortezomib and lenalidomide for patients ineligible for initial stem cell transplantation.
- Multiple Myeloma Management
- Stem Cell Transplantation
- Novel Drug Combinations
Transplant Complications
The investigator focuses on managing post-transplant complications, particularly graft versus host disease. Their research encompasses both acute and chronic GVHD, including the application of mesenchymal stromal cells and innovative treatments like apraglutide for steroid-refractory cases.
- Acute GVHD Treatment
- Chronic GVHD Management
- Cell-Based Therapies
Cellular Therapeutics
Research interests include advanced cellular therapies, particularly in solid tumors and cutaneous melanoma. The investigator works with CAR-T cell therapy and explores the potential of regulatory T-cells in various therapeutic applications.
- Solid Tumor Treatment
- Immunotherapy Development
- Cell-Based Interventions
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.